These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 26499499)

  • 1. Molecular modeling studies demonstrate key mutations that could affect the ligand recognition by influenza AH1N1 neuraminidase.
    Ramírez-Salinas GL; García-Machorro J; Quiliano M; Zimic M; Briz V; Rojas-Hernández S; Correa-Basurto J
    J Mol Model; 2015 Nov; 21(11):292. PubMed ID: 26499499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outside-binding site mutations modify the active site's shapes in neuraminidase from influenza A H1N1.
    Tolentino-Lopez L; Segura-Cabrera A; Reyes-Loyola P; Zimic M; Quiliano M; Briz V; Muñoz-Fernández A; Rodríguez-Pérez M; Ilizaliturri-Flores I; Correa-Basurto J
    Biopolymers; 2013 Jan; 99(1):10-21. PubMed ID: 23097226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theoretical studies on the susceptibility of oseltamivir against variants of 2009 A/H1N1 influenza neuraminidase.
    Li L; Li Y; Zhang L; Hou T
    J Chem Inf Model; 2012 Oct; 52(10):2715-29. PubMed ID: 22998323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting a cluster of arginine residues of neuraminidase to avoid oseltamivir resistance in influenza A (H1N1): a theoretical study.
    Gema LR; Tolentino-Lopez LE; Martínez-Ramos F; Padilla-Martínez I; García-Machorro J; Correa-Basurto J
    J Mol Model; 2015 Jan; 21(1):8. PubMed ID: 25605596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long time scale GPU dynamics reveal the mechanism of drug resistance of the dual mutant I223R/H275Y neuraminidase from H1N1-2009 influenza virus.
    Woods CJ; Malaisree M; Pattarapongdilok N; Sompornpisut P; Hannongbua S; Mulholland AJ
    Biochemistry; 2012 May; 51(21):4364-75. PubMed ID: 22574858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Understanding the cross-resistance of oseltamivir to H1N1 and H5N1 influenza A neuraminidase mutations using multidimensional computational analyses.
    Singh A; Soliman ME
    Drug Des Devel Ther; 2015; 9():4137-54. PubMed ID: 26257512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In silico study on multidrug resistance conferred by I223R/H275Y double mutant neuraminidase.
    Tan H; Wei K; Bao J; Zhou X
    Mol Biosyst; 2013 Nov; 9(11):2764-74. PubMed ID: 24056678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding.
    Behera AK; Basu S; Cherian SS
    Gene; 2015 Feb; 557(1):19-27. PubMed ID: 25479009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Homology modeling, docking, and molecular dynamics reveal HR1039 as a potent inhibitor of 2009 A(H1N1) influenza neuraminidase.
    Wang YT; Chan CH; Su ZY; Chen CL
    Biophys Chem; 2010 Mar; 147(1-2):74-80. PubMed ID: 20045243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation-induced loop opening and energetics for binding of tamiflu to influenza N8 neuraminidase.
    Kar P; Knecht V
    J Phys Chem B; 2012 May; 116(21):6137-49. PubMed ID: 22553951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the cause of oseltamivir resistance against mutant H274Y neuraminidase by molecular simulation approach.
    Karthick V; Shanthi V; Rajasekaran R; Ramanathan K
    Appl Biochem Biotechnol; 2012 May; 167(2):237-49. PubMed ID: 22544690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into susceptibility of antiviral drugs against the E119G mutant of 2009 influenza A (H1N1) neuraminidase by molecular dynamics simulations and free energy calculations.
    Pan P; Li L; Li Y; Li D; Hou T
    Antiviral Res; 2013 Nov; 100(2):356-64. PubMed ID: 24055835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding pattern of the long acting neuraminidase inhibitor laninamivir towards influenza A subtypes H5N1 and pandemic H1N1.
    Meeprasert A; Khuntawee W; Kamlungsua K; Nunthaboot N; Rungrotmongkol T; Hannongbua S
    J Mol Graph Model; 2012 Sep; 38():148-54. PubMed ID: 23079644
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microsecond Molecular Dynamics Simulations of Influenza Neuraminidase Suggest a Mechanism for the Increased Virulence of Stalk-Deletion Mutants.
    Durrant JD; Bush RM; Amaro RE
    J Phys Chem B; 2016 Aug; 120(33):8590-9. PubMed ID: 27141956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational analysis and determination of a highly conserved surface exposed segment in H5N1 avian flu and H1N1 swine flu neuraminidase.
    Ghosh A; Nandy A; Nandy P
    BMC Struct Biol; 2010 Feb; 10():6. PubMed ID: 20170556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights from investigating the interaction of oseltamivir (Tamiflu) with neuraminidase of the 2009 H1N1 swine flu virus.
    Wang SQ; Du QS; Huang RB; Zhang DW; Chou KC
    Biochem Biophys Res Commun; 2009 Aug; 386(3):432-6. PubMed ID: 19523442
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Theoretical analysis of the neuraminidase epitope of the Mexican A H1N1 influenza strain, and experimental studies on its interaction with rabbit and human hosts.
    Loyola PK; Campos-Rodríguez R; Bello M; Rojas-Hernández S; Zimic M; Quiliano M; Briz V; Muñoz-Fernández MA; Tolentino-López L; Correa-Basurto J
    Immunol Res; 2013 May; 56(1):44-60. PubMed ID: 23371837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In silico study of carvone derivatives as potential neuraminidase inhibitors.
    Jusoh N; Zainal H; Abdul Hamid AA; Bunnori NM; Abd Halim KB; Abd Hamid S
    J Mol Model; 2018 Mar; 24(4):93. PubMed ID: 29546582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Difluorosialic acids, potent novel influenza virus neuraminidase inhibitors, induce fewer drug resistance-associated neuraminidase mutations than does oseltamivir.
    Tai SH; Agafitei O; Gao Z; Liggins R; Petric M; Withers SG; Niikura M
    Virus Res; 2015 Dec; 210():126-32. PubMed ID: 26247418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.